New Borealis system and Aurora Evo enhancements expand high-parameter cytometry, automation, and workflow efficiency
Cytek Biosciences, Inc. will unveil new full spectrum flow cytometry innovations at CYTO 2026, taking place June 6–10, in West Palm Beach, Florida. Cytek will introduce the new 7-laser Cytek Borealis™ full spectrum flow cytometer with Deep Ultraviolet (DUV) and Infrared (IR) cFluor® reagents, alongside enhanced automation-ready configurations of the Cytek Aurora Evo system, designed to increase flexibility, scalability, and workflow efficiency for high-parameter cell analysis.
The 39th annual CYTO Congress, themed Cytometry: The Next Wave, will highlight emerging technologies shaping the future of cytometry. Cytek Biosciences continues to play a central role in this evolution by advancing high-parameter analysis with end-to-end cell analysis solutions tailored for a wide range of research and biopharma applications.
Cytek will also host two tutorial sessions at CYTO, focused on expanding the capabilities of flow cytometry and streamlining high-dimensional workflows:
CYTO 2026 attendees will see the debut of the Cytek Borealis system, a next-generation platform that combines full spectrum flow cytometry with future cellular imaging capabilities in a single instrument.
Available through an Early Access Program (EAP), the Cytek Borealis system features 120 detectors (110 fluorescence and 10 scatter) across seven laser lines, including newly added DUV and IR lasers. This expanded detection range enables the development of high-resolution 60-color panels, with the potential to go beyond this level of complexity.
To support these expanded optical capabilities, Cytek has developed DUV and IR cFluor reagents optimized for use with the Cytek Borealis system. These new dyes are available via EAP for custom panel design and evaluation, with broader commercial availability planned. This integrated solution allows researchers to access new spectral space and scale panel complexity in ways that are not currently available on other platforms.
The Cytek Borealis platform builds on Cytek’s expertise in high-parameter cytometry and incorporates future imaging capabilities acquired through its Luminex ImageStream assets. The result is a unified system designed to extend what can be learned from a single sample.
By integrating imaging with spectral detection, the Cytek Borealis system is intended to provide a more complete view of cellular behavior and structure.
Cytek will also highlight new automation and throughput enhancements to the Cytek Aurora Evo platform. These updated configurations are designed to enable integration of full spectrum flow cytometry into automated environments, increasing scalability and reducing the need for manual intervention.
Building on the Cytek Aurora Evo system’s existing automation and throughput features, including increased flow rates and automated startup and shutdown, Cytek is extending this foundation with new hardware capabilities and software API integrations. Scientists will be able to automate their full spectrum workflows by connecting the Cytek Aurora Evo system to robotic plate handling systems and third-party scheduling platforms.
These automation capabilities are particularly relevant for biopharma organizations and contract research organizations (CROs), where efficiency, reproducibility, and seamless system integration are critical for large-scale studies and high-throughput screening.
“We’re excited to be part of CYTO 2026, where the flow cytometry community comes together to explore new ideas and emerging technologies,” said Dr. Wenbin Jiang, CEO of Cytek Biosciences. “Our latest innovations reflect a continued commitment to expanding what is possible, delivering solutions that help researchers generate deeper insights from one sample with greater efficiency and confidence.”
The new standard for full spectrum flow cytometry
Cytek Biosciences, Inc. will unveil the new 7-laser Cytek Borealis™ full spectrum flow cytometer with Deep Ultraviolet (DUV) and Infrared (IR) cFluor® reagents. The company will also highlight enhanced automation-ready configurations of the Cytek Aurora Evo system, designed to increase flexibility, scalability, and workflow efficiency for high-parameter cell analysis in research and biopharma applications.
The Cytek Borealis system is a next-generation full spectrum flow cytometer that combines spectral flow cytometry with future cellular imaging capabilities in a single instrument. Available through an Early Access Program, it features 120 detectors (110 fluorescence and 10 scatter) across seven laser lines, including newly added DUV and IR lasers. This expanded detection range supports high-resolution 60-color panels, with potential for even greater complexity.
Cytek has developed DUV and IR cFluor reagents optimized for the Cytek Borealis system, enabling researchers to access new spectral space and scale panel complexity beyond what is currently available on other platforms.
Cytek is introducing new automation and throughput enhancements to the Cytek Aurora Evo platform to support integration into automated environments. Building on existing features such as increased flow rates and automated startup and shutdown, the updated configurations add new hardware capabilities and software API integrations.
These enhancements allow scientists to connect the Cytek Aurora Evo system to robotic plate handling systems and third-party scheduling platforms, improving scalability, reducing manual intervention, and supporting efficient, reproducible high-throughput studies for biopharma organizations and contract research organizations (CROs).
SelectScience Brands
Awards
© SelectScience 2026
Login
New to SelectScience?
Register for free today
Cytek Biosciences debuts Borealis spectral cytometer – SelectScience
Leave a Comment
